Hideki Takeshita

11PUBLICATIONS
50CO-AUTHORS
Occupational epidemiologyAutoimmunityCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersGender relations
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jul 13, 2026
Very Low Uptake in Workplace Semen Analysis Research: Formative Web-Based Cross-Sectional Follow-Up Survey Distinguishing Employees With Self-Reported Unawareness From Aware Nonparticipants.

|Sep 05, 2025
Immunoglobulin G4-Related Inflammatory Pseudotumor With Cystic Features Mimicking Renal Cancer.

Yuki Tanaka, Takahisa Yamashita, Kazuki Yokota

|Jul 08, 2025
Geographical Differences in the Management and Outcomes of Patients With Advanced Urothelial Carcinoma Treated With Pembrolizumab After Progression on Platinum-Based Chemotherapy: Results From ARON-2 Study.

Mimma Rizzo, Andrey Soares, Shilpa Gupta

|Mar 07, 2025
Two Cases of Revisional Urinary Diversion from Ureterocutaneostomy to Ileal Conduit: A Staged Urinary Diversion Strategy for Patients with Bladder Cancer in the Targeted and Immunotherapy Era.

Yuki Tanaka, Hideki Takeshita, Kazuki Yokota

|Feb 21, 2025
Real-Life Impact of Enfortumab Vedotin or Chemotherapy in the Sequential Treatment of Advanced Urothelial Carcinoma: The ARON-2 Retrospective Experience.

Mimma Rizzo, Franco Morelli, Yüksel Ürün

|Jul 24, 2024
Prognostic significance of inflammatory markers in patients with advanced renal cell carcinoma receiving nivolumab plus ipilimumab.

Takayuki Nakayama, Hideki Takeshita, Makoto Kagawa

Pageof 2

Frequent Collaborators

4 joint publications

Akihiro Yano

4 joint publications

Satoru Kawakami

3 joint publications

Yohei Okada

3 joint publications

Sachi Kitayama